Drugs / [18F]MPPF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01461083 | Sep 2011 → Nov 2012 | Parkinson disease | Institute for Neurodegenerative Disorders | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [18F]MPPF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01461083 ↗ |
| Route | Intravenous | “intravenous bolus injection” NCT01461083 ↗ |